Cisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only, Manufactured for: Accord Healthcare Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad 382 213, India. Mfg. Lic. No.: G/28/1336, NDC 16729-288-38
Published October 23, 2024 · Recall initiated: October 1, 2024
Summary
FDA records drug Class II recall D-0010-2025, published October 23, 2024 and initiated October 1, 2024. Recalling firm: ACCORD HEALTHCARE, INC.; Status: Terminated; Reported quantity: 11,214 vials; Lot: Lot #: P2202009, Exp. Date: 03/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications.
What to do
Voluntary: Firm initiated · Letter
Get an email if CISPLATIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CISPLATIN
- Manufacturer
- ACCORD HEALTHCARE, INC.
- Distributor
- Nationwide within the United States and PR
- UPC
- 0316729288385
- Lot
- Lot #: P2202009, Exp. Date: 03/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADuloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa PharmaceuticalOctober 23, 2024
- FDADapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India,October 23, 2024
- FDAAtovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc.,October 23, 2024
- FDAFirst Aid Antiseptic Ointment, Povidone Iodine USP 10%, Inactive Ingredients: mineral oil, petrolatum. NET Wt.October 23, 2024
- FDAEnterprise Imaging XERO Viewer- software application used for reference and diagnostic viewing ofOctober 16, 2024
- FDAMEDIHONEY Dressing with Active Leptospermum Honey Wound and Burn Dressing W/APPLICATOR, 1.5oz tube (ModelOctober 16, 2024
Questions about this recall
Was Cisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only, Manufactured for: Accord Healthcare Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad 382 213, India. Mfg. Lic. No.: G/28/1336, NDC 16729-288-38 recalled?
Yes. FDA published recall D-0010-2025 on October 23, 2024. Reported hazard: Failed Impurities/Degradation Specifications.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CISPLATIN. UPC: 0316729288385.